Teva Stock Surges on Earnings
This is a news story, published by Investor's Business Daily, that relates primarily to Teva Pharmaceutical news.
drug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsInvestor's Business Daily news
For more news from Investor's Business Daily, you can click here:
more news from Investor's Business DailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Teva stock. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Teva news, profit outlook news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Teva PharmaceuticalInvestor's Business Daily
•Health
Health
Teva Surges After Drugmaker Hikes Its Profit View
81% Informative
Analysts expected Teva Pharmaceutical to earn 52 cents per share on $3.89 billion in first-quarter sales.
Teva stock surged more than 8% to 17.50 in premarket trades.
The company also lowered the top side of its sales outlook by $200 million .
VR Score
84
Informative language
85
Neutral language
40
Article tone
formal
Language
English
Language complexity
23
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
2
Affiliate links
no affiliate links